We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$159M 2.28%
334,900
+229,900
+219% +$106M
QRVO icon
2
Qorvo
QRVO
$7.63B
$151M 2.16%
+963,210
New +$153M
ABBV icon
3
AbbVie
ABBV
$458B
$145M 2.08%
1,070,201
+289,792
+37% +$34.2M
ASML icon
4
ASML
ASML
$675B
$119M 1.7%
149,400
+147,640
+8,389% +$117M
LLY icon
5
Eli Lilly
LLY
$1.07T
$107M 1.53%
387,301
+71,198
+23% +$18M
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
$103M 1.48%
668,004
+90,300
+16% +$15.1M
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$95.2M 1.36%
883,103
-201,110
-19% -$21.9M
DHR icon
8
Danaher
DHR
$135B
$94.5M 1.35%
324,006
+128,692
+66% +$35.4M
JNJ icon
9
Johnson & Johnson
JNJ
$634B
$88.8M 1.27%
519,147
-244,085
-32% -$40M
COO icon
10
Cooper Companies
COO
$13.7B
$88.5M 1.27%
844,568
+233,188
+38% +$23.8M
MSFT icon
11
Microsoft
MSFT
$2.84T
$82.9M 1.19%
246,395
+87,848
+55% +$28.5M
ISRG icon
12
Intuitive Surgical
ISRG
$121B
$75.5M 1.08%
210,161
+141,086
+204% +$48.5M
RVMD icon
13
Revolution Medicines
RVMD
$40.2B
$73.7M 1.06%
2,930,038
+2,060,554
+237% +$58.1M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$3.91T
$71.9M 1.03%
496,680
-280,500
-36% -$40.4M
RCUS icon
15
Arcus Biosciences
RCUS
$3.57B
$69.1M 0.99%
1,706,425
+7,312
+0.4% +$284K
LEGN icon
16
Legend Biotech
LEGN
$4.3B
$68.9M 0.99%
1,478,666
+72
+0% +$3.65K
NATI
17
DELISTED
National Instruments Corp
NATI
$68.1M 0.98%
1,558,768
+342,098
+28% +$14.5M
APH icon
18
Amphenol
APH
$188B
$65.4M 0.94%
1,494,568
+607,522
+68% +$24.6M
ARW icon
19
Arrow Electronics
ARW
$10.9B
$65.3M 0.94%
486,443
+291,490
+150% +$35.8M
VSH icon
20
Vishay Intertechnology
VSH
$5.86B
$65M 0.93%
2,973,805
-15,497
-0.5% -$318K
ST icon
21
Sensata Technologies
ST
$6.65B
$61.2M 0.88%
992,260
+433,199
+77% +$25.2M
VIAV icon
22
Viavi Solutions
VIAV
$9.75B
$59.4M 0.85%
3,373,012
+359,784
+12% +$5.7M
NOW icon
23
ServiceNow
NOW
$102B
$58.7M 0.84%
452,465
+252,425
+126% +$33.1M
PFE icon
24
Pfizer
PFE
$140B
$58.4M 0.84%
989,623
-205,447
-17% -$10.2M
MU icon
25
Micron Technology
MU
$1.04T
$58M 0.83%
623,097
+205,734
+49% +$16.1M

Similar funds

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.